Clinical Trial Update: A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and early therapeutic activity of ANV419 in adults with advanced solid tumors, including lung cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Solid Tumors

Drugs mentioned

• ANV419

Snippet

Sponsor: Anaveon AG | Conditions: Advanced Solid Tumor, Adult Disease | Phase 1 | Status: COMPLETED